Vertex Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 48,303 | 0.0187% |
| State or Government | 291,504 | 0.113% |
| Individual Insiders | 404,721 | 0.157% |
| General Public | 15,883,125 | 6.15% |
| Institutions | 241,831,690 | 93.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 25,902,938 | US$10.5b | 0.99% | 0.54% | |||
| 22,282,180 | US$9.0b | 1.36% | 0.15% | |||
| 21,881,203 | US$8.9b | -3.12% | 0.16% | |||
| 12,231,338 | US$5.0b | -10.3% | 0.33% | |||
| 12,083,818 | US$4.9b | 0.37% | 0.2% | |||
| 7,039,738 | US$2.9b | -6.47% | 0.92% | |||
| 5,887,412 | US$2.4b | -14.1% | 0.22% | |||
| 5,673,419 | US$2.3b | 1.38% | 0.2% | |||
| 5,228,538 | US$2.1b | -19.9% | 0.33% | |||
| 4,919,802 | US$2.0b | -7.75% | 0.25% | |||
| 3,944,913 | US$1.6b | 3.88% | 1.01% | |||
| 3,625,802 | US$1.5b | -6.83% | 0.32% | |||
| 3,134,852 | US$1.3b | -0.9% | 1.79% | |||
| 3,042,288 | US$1.2b | 24.1% | 0.11% | |||
| 3,023,610 | US$1.2b | -3.29% | 0.17% | |||
| 2,750,047 | US$1.1b | 40.5% | 0.23% | |||
| 2,680,597 | US$1.1b | -4.73% | 0.18% | |||
| 2,592,575 | US$1.0b | -11.9% | 0.81% | |||
| 2,510,029 | US$1.0b | -14.6% | 0.25% | |||
| 2,430,665 | US$984.2m | 19.1% | 0.2% | |||
| 2,339,979 | US$947.5m | 41.1% | 0.41% | |||
| 1,916,116 | US$775.9m | -1.45% | 0.14% | |||
| 1,881,287 | US$761.8m | 0% | 0.21% | |||
| 1,611,579 | US$652.5m | 25.6% | 0.33% | |||
| 1,591,688 | US$644.5m | -4.35% | 0.96% |